-
Forward Look
A More Targeted PARP InhibitorEarly research suggests treatment could have higher potency and less toxicity for people with BRCA-related cancers.
by Marci A. Landsmann
-
Forward Look
Immunotherapy Improves Survival in Early-stage Kidney CancerPeople who have surgery to remove kidney cancer that has a high chance of recurrence must weigh benefits and risks of additional treatment.
by Christina Szalinski
-
Breast Cancer: Making Treatment Decisions
With additional treatment options and an emphasis on reducing side effects, patients with breast cancer have more decisions to make than ever before.
by Natalie Slivinski
-
Survivor Profile
From Fear to ActionMike Herman hasn’t let a multiple myeloma diagnosis stop him from advocating for himself and teaching others to do the same.
by Suzanne McBride
-
The Push for Inclusive Cancer Care
People with intellectual or developmental disabilities face obstacles to receiving appropriate cancer screening and treatment. Advocates are calling on the health care system to meet their needs and increase access to care.
by Thomas Celona
-
Get Involved
Happy FeetThe HallieStrong Foundation sends people receiving cancer treatment socks designed to put smiles on their faces.
by Thomas Celona
-
Facts and Stats
Treatment Advances Help Fuel Survival IncreasesPeople with localized esophageal cancer and advanced melanoma have benefited from improved cancer care.
by Thomas Celona
-
Making Cancer a Family Affair
Instead of hiding details of her metastatic breast cancer diagnosis from her children, Michelle Audoin opened the door for clear expectations and frank conversations.
by Michelle Audoin
-
Advocacy After Loss
Following her son’s death from peripheral T-cell lymphoma, Sandy McHugh keeps his memory alive through Jake’s Dragon Foundation.
by Thomas Celona
-
Telehealth Palliative Care Provides the Same Benefits as In-person Care
Researchers hope effective telehealth will increase access to palliative care for more cancer patients.
by Taneia Surles
Cancer Talk
Treating HER2-ultralow Breast Cancer
FDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
Lessons Learned as a Caregiver and PatientAfter caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore